Friday, May 02, 2014 7:54:49 AM
Also in the website it states... " As VG Life Sciences is a development stage company, its goal is to advance the treatment sufficiently in order to attract a larger pharmaceutical company for a partnership that will then carry the drug to market."
The first link is a presentation about Glioblastoma, which took place in Nov. 2013. Notice the names working with Dr. Newell and notice in the second link, money has been given to her lab that used to go directly to MD Anderson. Dr. Newell's work is getting noticed and if a partnership happens with Big Pharma, where will the stock price go?
https://soc-neuro-onc.conference-services.net/reports/template/onetextabstract.xml?xsl=template/onetextabstract.xsl&conferenceID=3676&abstractID=760854
Metabolic disruption as a mechanism to potentiate temozolomide therapy in glioblastoma multiforme
---------------------------------------------
http://www.brainpower5k.com/#!funding/c15y1
It is our pleasure to support the local efforts of area researchers, doctors in Central Texas. We are thrilled to be a major contributor to research at the Scott & White Healthcare Brain Tumor Center with Ekokobe Fonkem, DO; Eromata Ebwe, BS, DC and Aleksej Zuzek, PhD.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM